Draft: not yet reviewed for teaching
The Positive Urine Culture: Asymptomatic Bacteriuria
Separate bacteriuria from infection, stop reflexive urine testing, and know the two groups where treatment helps. About 15 minutes.
- Distinguish asymptomatic bacteriuria (ASB) from UTI by requiring localizing urinary symptoms or systemic signs with a urinary source
- Withhold urine testing and antibiotics in groups where treating ASB doesn't help (older adults, diabetes, catheters, transplant >1 month, nonurologic surgery)
- Screen and treat in the two groups where it does help, pregnancy and endoscopic urologic procedures
- Interpret pyuria correctly and avoid urine cultures for delirium, falls, or cloudy or smelly urine
- Describe the harms of treating ASB and the system changes that reduce it
The 3:30 AM page
Mrs. Park, 82, is on hospital day 2 for right lower lobe community-acquired pneumonia, improving on ceftriaxone and azithromycin. She has type 2 diabetes (A1c 7.4%), hypertension, osteoarthritis, and mild cognitive impairment; at baseline she lives with her daughter and is independent in ADLs. No urinary catheter.
The night nurse pages: Mrs. Park is confused and agitated, trying to climb out of bed and pulling at her IV. Her daughter says she "isn't herself." The urine in the bedpan is "dark and strong-smelling," and the nurse asks whether to send a urine culture and start something for a UTI.
- Vitals: T 37.1°C, HR 92, BP 148/82, RR 18, SpO₂ 95% on 2 L
- Exam: inattentive, oriented to person only (baseline oriented ×3). No suprapubic or CVA tenderness. Can't reliably report urinary symptoms. Improving right basal crackles. No new focal deficits.
- Other: WBC 9.8 (13.1 on admission), creatinine 0.9 (baseline). Poor oral intake overnight. Last bowel movement 3 days ago. Two doses of as-needed oxycodone in the last 12 hours, and diphenhydramine at 22:00 for sleep.
The nurse asks for a urine culture and empiric antibiotics. What is the most appropriate next step?
New confusion plus smelly urine is the most common, and lowest-yield, path to treating ASB. Treating bacteriuria hasn't been shown to improve delirium, and it adds C. difficile risk and adverse events [1, 13, 14]. She is afebrile and stable, and there are much likelier culprits on her medication list.
This sets the trap. Over 90% of patients with ASB have pyuria [1, 6], so an abnormal UA plus a positive culture will almost certainly be read as "UTI" and drive treatment. Diagnostic stewardship means not ordering the test without a urinary indication [7].
Empiric sepsis treatment is for patients with systemic instability and no other source. Mrs. Park is afebrile and normotensive with a falling WBC and an improving known infection [1].
IDSA strongly recommends that older adults with delirium or falls, and no localizing urinary symptoms or systemic signs, be evaluated for other causes and observed rather than cultured and treated [1]. Here the high-yield precipitants are an anticholinergic (diphenhydramine), opioids, 3 days of constipation, and poor intake.
What happened: bladder scan normal. The team stopped sedating medications, treated constipation, encouraged hydration, and used nonpharmacologic delirium measures.
Delirium is rarely a urinary symptom
Delirium and bacteriuria are both common in older inpatients, so they often coexist without one causing the other. Up to half of long-term care residents have ASB at any given time [1].
Before thinking about urine, check:
- Medications: anticholinergics, sedatives, opioids, recent changes
- Hypoxia, hypercapnia, hypoglycemia, sodium, calcium
- Pain, urinary retention, constipation
- Sleep disruption, sensory deprivation, restraints
- New neurologic event, or infection at another site
The evidence: in a prospective cohort of delirious medical inpatients, treating asymptomatic bacteriuria didn't improve outcomes, and the treated group had worse functional recovery [12]. A 2024 systematic review found no study showing that antibiotics help delirious older adults with pyuria or bacteriuria and no clear UTI, though the evidence is limited and mostly observational [14]. A randomized trial is now underway [18]. Until it reports, treating the urine is not the evidence-based default.
Answering the page
The nurse is worried, and the daughter is at the bedside. Saying no works better when you explain what you are doing.
You (to the nurse): Thanks for calling. I'll come see her. She has no fever and no urinary symptoms, and she got Benadryl and oxycodone tonight, which are much likelier causes. Let's hold those, check a bladder scan and glucose, and I'd rather not send urine. A positive culture is common at her age even without infection, and treating it can cause harm. Please call me if she spikes a fever, her pressure drops, or she has new urinary symptoms.
You (to the daughter): Confusion at night is really common in older adults in the hospital, especially with some of the medicines she got this evening. We're stopping those and helping her sleep and stay oriented. Many people her age have bacteria in their urine that don't cause infection, and antibiotics for that can cause diarrhea and other problems without helping her thinking. We're watching her closely and will treat any real infection.
- Name the alternative cause and the plan, not just the "no"
- Give clear call-back criteria so the nurse has a safety net
- Document "delirium, likely medication-related; no urinary indication for testing"
The culture that got sent anyway
A urine culture had already been collected on admission as part of a "pan-culture" order. It now grows E. coli >100,000 CFU/mL, pan-susceptible. The UA from the same specimen shows 25 to 50 WBC/hpf, positive leukocyte esterase, negative nitrite.
By morning, after stopping the sedating medications and treating constipation, Mrs. Park is back to baseline. She remains afebrile with no dysuria.
How should this positive urine culture change management?
A positive culture plus pyuria is exactly the pattern that drives overtreatment. Pyuria is present in over 90% of ASB and can't confirm UTI [1, 6]. Her delirium resolved when its real causes were removed.
A short course is still treatment of ASB, with the same harms (adverse drug events, resistance) and no benefit [1, 3]. No amount of antibiotic makes treating ASB appropriate here.
Repeating the culture adds more data to misinterpret. The decision rests on her symptoms, not on reconfirming colonization [1, 7].
Bacteriuria plus pyuria in an afebrile, now-lucid patient with no urinary symptoms is ASB by definition. Neither older age nor diabetes is a reason to treat [1]. In a randomized trial in women with diabetes and ASB, antibiotics didn't reduce symptomatic UTI and caused more adverse effects [8].
What happened: the team documented "Asymptomatic bacteriuria, no treatment indicated" so the next team wouldn't start antibiotics.
Pyuria doesn't settle it, and treatment isn't free
Pyuria: most ASB comes with pyuria, so pyuria can't separate ASB from UTI [1, 6]. In older women, the usual >10 WBC/µL cutoff is highly sensitive but only about 36% specific for UTI [11]. Absence of pyuria makes UTI unlikely, but presence proves nothing.
No benefit: in a Cochrane review of randomized trials in nonpregnant adults, antibiotics for ASB cleared the bacteria but didn't reduce symptomatic UTI, complications, or death [3].
Real harms:
- Nearly 4 times as many adverse events with treatment (RR 3.77) [3]
- Treating ASB was independently associated with C. difficile within 90 days, and with readmission, in a hospital cohort [13]
- In 46 Michigan hospitals, over 80% of inpatients with ASB were treated. Treatment was associated with a 37% longer stay after urine testing and no improvement in mortality or readmissions [6].
- In young women with recurrent UTI, treating ASB tripled symptomatic recurrence (46.8% vs 13.1% at last follow-up) [5]
Later that day you admit Ms. Alvarez, 26, at 14 weeks' gestation, for hyperemesis. She has no urinary symptoms. Her routine prenatal urine culture from 3 days ago grew Klebsiella pneumoniae 100,000 CFU/mL, susceptible to nitrofurantoin and cephalexin.
How should this be managed?
Pregnancy is the main exception. Treatment reduces pyelonephritis (RR 0.24) and low birth weight (RR 0.64) [4]. "Never treat ASB" is the overcorrection this case is meant to catch.
Treating is right, but fluoroquinolones are generally avoided in pregnancy when safer, susceptible options exist [15].
Deferring leaves her untreated through the period of risk. ASB found in pregnancy should be treated when detected [1].
IDSA recommends screening and treating ASB in pregnancy, with a 4 to 7 day course [1]. USPSTF recommends screening with a urine culture early in pregnancy (Grade B) [2]. ACOG suggests 5 to 7 days [15]. Choose the agent based on susceptibilities and trimester. Neither IDSA nor ACOG requires a routine test of cure, so coordinate follow-up with OB [1, 15].
The two exceptions
1. Pregnancy. Screen once early with a urine culture, and treat if positive [1, 2].
2. Before endoscopic urologic procedures that break the mucosa (for example, TURP). Get a preoperative culture and give targeted therapy as a short course (1 to 2 doses) starting 30 to 60 minutes before the procedure [1]. Untreated bacteriuria before TURP is associated with postoperative bacteremia and sepsis.
Not exceptions: older age, diabetes, indwelling catheters, kidney transplant more than 1 month out [9], spinal cord injury, and nonurologic surgery such as joint replacement [1].
Gray zones (individualize with specialist input): kidney transplant in the first month and prolonged high-risk neutropenia [1].
Mr. Weiss, 71, is admitted for elective TURP. He has no urinary symptoms. The preoperative culture grows Proteus mirabilis 100,000 CFU/mL, susceptible to TMP-SMX and ciprofloxacin.
How should the positive culture be managed?
This is one of the two exceptions. Bacteriuria before mucosa-disrupting urologic procedures predicts postoperative bacteremia and sepsis [1].
Unnecessary. Targeted perioperative therapy is enough [1].
Longer courses add antibiotic exposure and resistance without added benefit [1].
IDSA strongly recommends screening and treating ASB before endoscopic urologic procedures with expected mucosal trauma, using 1 to 2 culture-directed doses started 30 to 60 minutes before the procedure [1]. A recent large cohort confirmed preoperative bacteriuria is a risk factor for postoperative infection but left some uncertainty about how much treatment reduces it [17]. The recommendation stands.
The deciding variable: a planned urologic procedure that breaks the mucosa.
Mr. Odhiambo, 68, has a chronic indwelling catheter for neurogenic bladder. He arrives with T 39.2°C, rigors, HR 118, BP 92/58, new suprapubic and flank pain, confusion, and lactate 3.1. No respiratory, abdominal, skin, or line source. Urine from a freshly replaced catheter grows Pseudomonas aeruginosa.
What is the most appropriate management?
"Don't treat catheter bacteriuria" applies only when the patient is asymptomatic. He is septic with a likely urinary source [1].
Replacing a long-dwelling catheter is reasonable, but withholding antibiotics in sepsis is unsafe [1, 10].
Waiting for a repeat culture dangerously delays treatment in a septic patient.
This is a symptomatic catheter-associated UTI with sepsis: fever, hypotension, localizing pain, and no other source [1]. Replacing a long-dwelling catheter and sending the culture from the new one is good practice [10].
The deciding variable: systemic signs and localizing pain with no other source, exactly what Mrs. Park didn't have.
Reading the evidence. The Cochrane pregnancy review reports that treating ASB reduces pyelonephritis with a relative risk of 0.24 [4]. A colleague says: "That's a 76% reduction, so every pregnant patient with ASB benefits a lot."
But most of those trials are from the 1960s to 1980s, when untreated pyelonephritis rates were about 20% to 35%. In a more recent cohort, the rate in untreated ASB was about 2.4% [16].
Which statement is most accurate?
The classic relative-risk error. Absolute benefit depends on how common the outcome is without treatment.
Overreach. The relative effect likely persists, and pyelonephritis in pregnancy is serious, so guidelines still recommend treatment [1, 2].
Old trials have limitations, but that doesn't make their findings uninformative.
RR 0.24 applied to a 30% baseline prevents about 23 cases per 100 treated (NNT about 4). Applied to 2.4%, it prevents about 1.8 per 100 (NNT about 55).
That's why USPSTF lowered its pregnancy recommendation from Grade A to Grade B while still recommending screening [2]. The same reasoning applies whenever an old trial's relative effect is used for today's patients.
Fix the system, not just the prescription
In a 46-hospital Michigan initiative, ASB fell from 34% to 23% of positive urine cultures. Nearly all of the improvement came from ordering fewer unnecessary cultures, not from convincing clinicians to ignore positive results [7]. Once a positive culture was on the screen, about 3 in 4 patients with ASB were still treated.
What works on your unit:
- Don't order urine studies without a urinary indication, including in admission "pan-culture" bundles
- Don't send urine cultures for cloudy or smelly urine, or as a routine test of cure [10]
- Use reflex-to-culture criteria, and laboratory reporting that discourages reflexive treatment
- Document "ASB, no treatment indicated" so the next team doesn't start antibiotics
- A positive urine culture is a lab finding, not a diagnosis. Treat the patient's symptoms, not the urine.
- Diagnose UTI only with bacteriuria plus localizing urinary symptoms or systemic signs with no other source
- Work up delirium and falls for common reversible causes first, without reflexive urine testing
- Pyuria can't confirm UTI. Its absence helps rule UTI out.
- Treat ASB in only two groups: pregnancy, and before urologic procedures that break the mucosa
- If the patient is septic with no other source, empiric treatment is reasonable while you keep looking
Done. A few follow-up questions will appear under Review over the next several weeks.
References
- Nicolle LE, Gupta K, Bradley SF, et al. Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2019;68(10):e83-e110.
- US Preventive Services Task Force. Screening for Asymptomatic Bacteriuria in Adults: Recommendation Statement. JAMA. 2019;322(12):1188-1194.
- Zalmanovici Trestioreanu A, Lador A, Sauerbrun-Cutler MT, Leibovici L. Antibiotics for asymptomatic bacteriuria. Cochrane Database Syst Rev. 2015;(4):CD009534.
- Smaill FM, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev. 2019;(11):CD000490.
- Cai T, Mazzoli S, Mondaini N, et al. The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat? Clin Infect Dis. 2012;55(6):771-777.
- Petty LA, Vaughn VM, Flanders SA, et al. Risk factors and outcomes associated with treatment of asymptomatic bacteriuria in hospitalized patients. JAMA Intern Med. 2019;179(11):1519-1527.
- Vaughn VM, Gupta A, Petty LA, et al. A statewide quality initiative to reduce unnecessary antibiotic treatment of asymptomatic bacteriuria. JAMA Intern Med. 2023;183(9).
- Harding GKM, Zhanel GG, Nicolle LE, Cheang M. Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med. 2002;347(20):1576-1583.
- Coussement J, Kamar N, Matignon M, et al. Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): a pragmatic, multicentre, randomized, controlled trial. Clin Microbiol Infect. 2021;27(3).
- Patel PK, Advani SD, Kofman AD, et al. Strategies to prevent catheter-associated urinary tract infections in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol. 2023;44(8):1209-1231.
- Bilsen MP, Aantjes MJ, van Andel E, et al. Current pyuria cutoffs promote inappropriate urinary tract infection diagnosis in older women. Clin Infect Dis. 2023.
- Dasgupta M, Brymer C, Elsayed S. Treatment of asymptomatic UTI in older delirious medical in-patients: a prospective cohort study. Arch Gerontol Geriatr. 2017;72:127-134.
- Shpunt Y, Estrin I, Levi Y, et al. Antimicrobial use for asymptomatic bacteriuria: first, do no harm. Infect Control Hosp Epidemiol. 2021;42:37-42.
- Stall NM, Kandel C, Reppas-Rindlisbacher C, et al. Antibiotics for delirium in older adults with pyuria or bacteriuria: a systematic review. J Am Geriatr Soc. 2024;72(8):2566-2578.
- American College of Obstetricians and Gynecologists. Urinary tract infections in pregnant individuals. Clinical Consensus No. 4. Obstet Gynecol. 2023;142(2):435-445.
- Kazemier BM, Koningstein FN, Schneeberger C, et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infect Dis. 2015;15(11).
- Kutchukian S, Gondran-Tellier B, Dinh A, et al. Asymptomatic bacteriuria and urological surgery: risk factor or not? Results from the national and multicenter TOCUS database. J Urol. 2024;212(3):461-469.
- Fralick M, Stall NM, Zorcic K, et al. Antibiotics for delirium in older adults with no clear urinary tract infection: a multicentre, pragmatic, randomized trial (vanguard results). J Am Geriatr Soc. 2026;74(7):1964-1970.
Content last reviewed October 14, 2026.